Brief: Flerie Writes Down Value Of Holding In Empros Pharma
30/09/2026 14:53
BRIEF-Flerie Writes Down Value Of Holding In Empros Pharma Sept 30 (Reuters) - Flerie AB FLERIE.ST:
WRITES DOWN VALUE OF HOLDING IN EMPROS PHARMA
WRITE-DOWN REDUCES FLERIE'S NAV BY SEK 2.66 PER SHARE
Source text: ID:nMFNbr2DMX
Further company coverage: FLERIE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen